KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Current Assets: 2009-2025

Historic Current Assets for Exact Sciences (EXAS) over the last 17 years, with Sep 2025 value amounting to $1.6 billion.

  • Exact Sciences' Current Assets rose 3.76% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 3.76%. This contributed to the annual value of $1.6 billion for FY2024, which is 31.57% up from last year.
  • Per Exact Sciences' latest filing, its Current Assets stood at $1.6 billion for Q3 2025, which was up 5.50% from $1.5 billion recorded in Q2 2025.
  • Exact Sciences' 5-year Current Assets high stood at $1.8 billion for Q1 2021, and its period low was $982.3 million during Q4 2022.
  • For the 3-year period, Exact Sciences' Current Assets averaged around $1.3 billion, with its median value being $1.4 billion (2025).
  • As far as peak fluctuations go, Exact Sciences' Current Assets tumbled by 35.13% in 2021, and later skyrocketed by 33.53% in 2024.
  • Exact Sciences' Current Assets (Quarterly) stood at $1.4 billion in 2021, then plummeted by 31.13% to $982.3 million in 2022, then rose by 21.59% to $1.2 billion in 2023, then skyrocketed by 31.57% to $1.6 billion in 2024, then rose by 3.76% to $1.6 billion in 2025.
  • Its Current Assets was $1.6 billion in Q3 2025, compared to $1.5 billion in Q2 2025 and $1.4 billion in Q1 2025.